SSG
PRAH

Summit Securities Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Summit Securities Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,092
Closed -$267K – 398
2017
Q1 		$267K Buy
+4,092
New +$241K 0.08% 244

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Summit Securities Group's PRAH Position: Q2 2017 in Review

Summit Securities Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 4,092 shares — an estimated $267K sold.

Summit Securities Group first reported a position in PRAH in Q1 2017 and held it in 1 quarter. The position peaked at $267K in Q1 2017. 235 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

  • Summit Securities Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
  • Summit Securities Group sold 4,092 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $267K.
  • Summit Securities Group first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 1 quarter.
  • Summit Securities Group's PRA Health Sciences, Inc. position peaked at $267K in Q1 2017.
  • 235 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Summit Securities Group's 13F filing for Q2 2017, filed 2 Aug 2017.